Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Accelerate Diagnosti (AXDX)

Accelerate Diagnosti (AXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 27,123
  • Shares Outstanding, K 22,051
  • Annual Sales, $ 12,060 K
  • Annual Income, $ -61,620 K
  • 60-Month Beta 0.57
  • Price/Sales 2.29
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AXDX with:

Options Overview Details

View History
  • Implied Volatility 350.52% ( +45.19%)
  • Historical Volatility 64.69%
  • IV Percentile 82%
  • IV Rank 38.95%
  • IV High 890.29% on 02/06/24
  • IV Low 6.08% on 12/12/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 2
  • Volume Avg (30-Day) 8
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 277
  • Open Int (30-Day) 353

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.55
  • Number of Estimates 1
  • High Estimate -0.55
  • Low Estimate -0.55
  • Prior Year -2.36
  • Growth Rate Est. (year over year) +76.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0800 +20.37%
on 07/22/24
1.3000 unch
on 07/26/24
+0.1300 (+11.11%)
since 06/26/24
3-Month
0.8341 +55.86%
on 05/09/24
1.6000 -18.75%
on 05/29/24
+0.3699 (+39.77%)
since 04/26/24
52-Week
0.7300 +78.08%
on 04/18/24
7.5800 -82.85%
on 08/04/23
-4.7200 (-78.41%)
since 07/26/23

Most Recent Stories

More News
Accelerate Diagnostics: Q1 Earnings Snapshot

Accelerate Diagnostics: Q1 Earnings Snapshot

AXDX : 1.3000 (+5.69%)
Accelerate Diagnostics: Q3 Earnings Snapshot

Accelerate Diagnostics: Q3 Earnings Snapshot

AXDX : 1.3000 (+5.69%)
Accelerate Diagnostics: Q2 Earnings Snapshot

Accelerate Diagnostics: Q2 Earnings Snapshot

AXDX : 1.3000 (+5.69%)
Accelerate Diagnostics Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter for the period ended June 30, 2023....

AXDX : 1.3000 (+5.69%)
Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter Results

/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, August 10, 2023, at 4:30 p....

AXDX : 1.3000 (+5.69%)
Accelerate Diagnostics: Q1 Earnings Snapshot

Accelerate Diagnostics: Q1 Earnings Snapshot

AXDX : 1.3000 (+5.69%)
Accelerate Diagnostics Reports First Quarter 2023 Financial Results

/PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the first quarter for the period ended March 31, 2023. "Our...

AXDX : 1.3000 (+5.69%)
Accelerate Diagnostics scheduled call to review 2023 first quarter results

/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, May 11, 2023, at 4:30 p.m....

AXDX : 1.3000 (+5.69%)
Accelerate Diagnostics: Q4 Earnings Snapshot

Accelerate Diagnostics: Q4 Earnings Snapshot

AXDX : 1.3000 (+5.69%)
Accelerate Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results

/PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended December 31, 2022. "In...

AXDX : 1.3000 (+5.69%)

Business Summary

Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections...

See More

Key Turning Points

3rd Resistance Point 1.4067
2nd Resistance Point 1.3533
1st Resistance Point 1.3267
Last Price 1.3000
1st Support Level 1.2467
2nd Support Level 1.1933
3rd Support Level 1.1667

See More

52-Week High 7.5800
Fibonacci 61.8% 4.9633
Fibonacci 50% 4.1550
Fibonacci 38.2% 3.3467
Last Price 1.3000
52-Week Low 0.7300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar